We have screened physiological TF activities to evaluate their role in leukemia when deregulated; here, to identify novel and developmentally significant networks, we focus on the TF groups NKL homeodomain, TALE homeodomain, ETS, and T-box, and their roles in normal and malignant B-cells. This evidence concerns the gene TF and leukemia.